CA1339080C - Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire - Google Patents

Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire

Info

Publication number
CA1339080C
CA1339080C CA000610327A CA610327A CA1339080C CA 1339080 C CA1339080 C CA 1339080C CA 000610327 A CA000610327 A CA 000610327A CA 610327 A CA610327 A CA 610327A CA 1339080 C CA1339080 C CA 1339080C
Authority
CA
Canada
Prior art keywords
drug
milligrams
patient
lollipop
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000610327A
Other languages
English (en)
Inventor
Theodore H. Stanley
Brian Hague
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Priority to CA000610327A priority Critical patent/CA1339080C/fr
Application granted granted Critical
Publication of CA1339080C publication Critical patent/CA1339080C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA000610327A 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire Expired - Fee Related CA1339080C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000610327A CA1339080C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000610327A CA1339080C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire

Publications (1)

Publication Number Publication Date
CA1339080C true CA1339080C (fr) 1997-07-29

Family

ID=4140556

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000610327A Expired - Fee Related CA1339080C (fr) 1989-09-05 1989-09-05 Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire

Country Status (1)

Country Link
CA (1) CA1339080C (fr)

Similar Documents

Publication Publication Date Title
US5484602A (en) Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
EP0490891B1 (fr) Matrice contenant un medicament
US6893654B2 (en) Two-stage transmucosal medicine delivery system for symptom relief
US4863737A (en) Compositions and methods of manufacture of compressed powder medicaments
CZ289643B6 (cs) Lék pro léčbu bolesti v krku obsahující flurbiprofen
US6103257A (en) System for delivering pharmaceuticals to the buccal mucosa
US20230225994A1 (en) Sublingual epinephrine formulations and methods of use
EP0493380B1 (fr) Methode de preparation permettant l'administration non invasive de medicaments lipophiles doses en fonction de l'effet recherche
CA1339080C (fr) Methodes et compositions pour l'administration dose-effet non invasive de medicaments agissant au niveau cardiovascular ou renovasculaire
Doring Evaluation of an alphaprodine-hydroxyzine combination as a sedative agent in the treatment of the pediatric dental patient
Makwana et al. Chewing gum: A modern approach to oral mucosal drug delivery
JP2023553204A (ja) 歯科処置における鎮静のためのクロニジン及びミダゾラムの経口製剤
AU684888B2 (en) Method and compositions for noninvasive dose to effect administration of lipophilic drugs
CA1339075C (fr) Methodes et compositions pour l'administration dose-effet non invasive de medicaments lipophiles
JP2801050B2 (ja) 圧縮粉末薬剤
CA1339190C (fr) Compositions et methodes de fabrication de medicaments dans des poudres comprimees

Legal Events

Date Code Title Description
MKLA Lapsed